Ho Lin

national chung hsing university

H指数:36

被引数:4,113

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Study of benign prostatic hyperplasia and androgen pathway manipulation on lung cancer survivals

良性前列腺增生及雄激素通路调控对肺癌生存率的影响研究

Journal of Advanced Research

IF13

2026-07-070

OAAI

Correction: SPHK1 promotes bladder cancer metastasis via PD-L2/c-Src/FAK signaling cascade

更正：SPHK1通过PD-L2/c-Src/FAK信号级联促进膀胱癌转移

Cell Death & Disease

IF9.6

2026-05-180

OAAI

Applying next-generation sequencing to predict short progression-free survival in patients with advanced EGFR-mutant lung adenocarcinoma receiving epidermal growth factor receptor tyrosine kinase inhibitors

ANTI-CANCER DRUGS

IF2.2

2025-11-010

PRE

Alisertib inhibits acute myeloid leukemia cell growth by inhibiting STAT3 activation

Alisertib通过抑制STAT3激活抑制急性髓系白血病细胞生长

Toxicology and Applied Pharmacology

IF3.4

2025-06-250

PRE

The roles and mechanism of IFIT5 in bladder cancer epithelial-mesenchymal transition and progression (vol 16, 339, 2025)

IFIT5在膀胱癌上皮-间质转化及进展中的作用和机制（卷16，339，2025）

CELL DEATH & DISEASE

IF9.6

2025-04-250

CDK5 targets p21CIP1 to regulate thyroid cancer cell proliferation and malignancy in patients

CDK5将p21CIP1作为靶点，以调节甲状腺癌细胞的增殖和患者的恶性程度。

MOLECULAR MEDICINE REPORTS

IF3.5

2025-04-240

PRE

Dinaciclib Interrupts Cell Cycle and Induces Apoptosis in Oral Squamous Cell Carcinoma: Mechanistic Insights and Therapeutic Potential

Dinaciclib中断细胞周期并诱导口腔鳞状细胞癌的凋亡：机制见解与治疗潜力

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

IF4.9

2025-02-280

SPHK1 promotes bladder cancer metastasis via PD-L2/c-Src/FAK signaling cascade

CELL DEATH & DISEASE

IF9.6

2024-09-165

OAAI

Metformin inhibits nerve growth factor-induced sympathetic neuron differentiation through p35/CDK5 inhibition

二甲双胍通过抑制p35/CDK5抑制神经生长因子诱导的交感神经元分化

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

IF4.7

2024-06-013

PRE

RAGE potentiates EGFR signaling and interferes with the anticancer effect of gefitinib on NSCLC cells

RAGE增强EGFR信号通路并干扰吉非替尼对NSCLC细胞的抗癌作用

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

IF4.7

2023-11-014

PRE

Pamiparib combined with surufatinib as a neoadjuvant therapy for advanced ovarian cancer patients in the entire population: Preliminary results of a prospective, exploratory, single-arm phase II clinical study

ANNALS OF ONCOLOGY

IF65.4

2023-10-011

PRE

Tislelizumab combined with gemcitabine/cisplatin in muscle-invasive bladder cancer with selective bladder preservation for clinical complete response (cCR) patients: A real-world multicenter study

Tislelizumab联合吉西他滨/顺铂治疗临床完全缓解 (cCR) 患者选择性膀胱保留的肌层浸润性膀胱癌: 一项真实世界的多中心研究

ANNALS OF ONCOLOGY

IF65.4

2023-10-010

OAAI

Reactivation of Hepatitis B Virus in Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Treatment

JOURNAL OF CLINICAL MEDICINE

IF2.9

2022-12-284

OAAI

Presence and clinical significance of acellular mucin pools in resected rectal cancer with pathological complete response after pre-operative chemoradiotherapy

HISTOPATHOLOGY

IF4.1

2022-09-222

PRE

Developing New Treatment Options for Castration-Resistant Prostate Cancer and Recurrent Disease

BIOMEDICINES

IF3.9

2022-08-0311

OAAI

The driver role of JAK-STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy- and castration-resistant prostate cancer

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2022-07-3119

OAAI

The central role of Sphingosine kinase 1 in the development of neuroendocrine prostate cancer (NEPC): A new targeted therapy of NEPC

鞘氨醇激酶1在神经内分泌前列腺癌 (NEPC) 发展中的核心作用: NEPC的新靶向治疗

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2022-02-2010

OAAI

Bacterial Genotoxin-Coated Nanoparticles for Radiotherapy Sensitization in Prostate Cancer

BIOMEDICINES

IF3.9

2021-02-047

OAAI

The Roles of ZnT1 and ZnT4 in Glucose-Stimulated Zinc Secretion in Prostate Epithelial Cells

MOLECULAR IMAGING AND BIOLOGY

IF2.5

2020-11-0210

OAAI

Interferon induces lineage plasticity of castration-resistant prostate cancer

CANCER RESEARCH

IF16.6

2020-08-150

PRE

Ho Lin

个人简介

教育背景

工作经历

荣誉奖项

研究方向